US stocks end up on earnings, data showing a resilient economy and trade deall optimism. S&P 500 and Nasdaq score records ...

McKesson reported strong FY25 growth, plans spin-off to focus on oncology and biopharma. MCK is an undervalued stock upgraded ...

Key Points - Adjusted operating earnings per share (Non-GAAP) beat estimates at $9.11 for Q2 2025, while Non-GAAP revenue slightly missed expectations at $4.30 billion. Wealth management segment ...

HCA Healthcare Inc. (NYSE:HCA), one of the nation’s largest hospital operators, announced robust second-quarter 2025 ...

Merafe Resources has reported a significant decline in its share price and earnings per share, attributing the downturn to ...

NatWest delivered strong Q2 2025 results, clearing analyst expectations on both revenue and profit. Click here to find out ...

Shares of Pathward Financial were trading at $80.15 as of July 24. Over the last 52-week period, shares are up 18.55%. Given ...

Paul Mueller Company (OTC: MUEL) corrects an earlier release which contained an error in the earnings per share for the three ...

AstraZeneca's shares are up 3.5% over the year to date but remain down 11% over the past 52 weeks.

The student loan giant fell far short of Wall Street's expectations, but its leaders say President Trump's "Big Beautiful ...

Stock futures are inching higher, with the Nasdaq at another record high. Fueled in part by Alphabet’s stronger-than-expected ...

Not every stock is hitting fresh highs. These two companies you know are cheap in an otherwise ascending market.